Report copyright - A randomized, double ‑ blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients
Please pass captcha verification before submit form
Please pass captcha verification before submit form